Fundraising Fox
Akibah Health
Techstars '14San Jose, US · Founded 2013 · Delaware corporation · 1 employees on LinkedIn · 1 known investors
Find your way into Akibah Health
Sign up to see every warm intro you have to Akibah Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Akibah Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Akibah Health makes GluCase, a subscription smartphone-case glucometer and app for data-driven diabetes management.
Also known as Akibah · AkibaH · AkibaH Health
Founders & leadership
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$17.5K disclosed across 1 round · 2017
▶$17.5KraisedMar 2017 · 3 investors · Other Health CareRule 506(c)
- Fathi AbdelsalamExecutive Officer
- Offering amount
- $1M
- Amount sold
- $17.5K
- Minimum investment
- $2.5K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Sep 2026Akibah Health (also styled AkibaH) is a San Jose, California mobile health company applying smartphone-integrated hardware and data science to type 1 and type 2 diabetes management. Its flagship product, GluCase, combines a blood glucose monitoring kit and a Bluetooth module inside a smartphone case, described by the company as an OtterBox-enabled smartphone case glucometer, so that users do not need to carry separate testing supplies.
GluCase is paired with a mobile application that places glucose readings in the context of other behavioral data such as physical activity and diet, and provides real-time, data-driven coaching and predictive-analytics-based recommendations. The company is classified in listings under medical devices/hardware and mobile health, serving consumers directly.
Alongside the product, the company published consumer education content on diabetes topics including exercise with diabetes, selecting glucose test strips, nutrition, and diabetes-related kidney disease risk.
Founding story
Akibah Health was founded in July 2013 in San Jose, California.
Business model
Akibah Health sells GluCase on a monthly subscription basis: subscribers receive the GluCase smartphone case, an ongoing monthly supply of test strips, and access to a companion mobile application that delivers behavioral guidance derived from predictive analytics. The recurring consumable and software bundle ties hardware distribution to an ongoing service relationship with the individual user.
Recurring subscription revenue from monthly plans covering the GluCase device, consumable test strip resupply, and mobile app access.
Traction
Public listings report five employees as of early 2024 and a headcount band of 1-10, a product described as full product ready, participation in the Techstars Sprint 2014 accelerator, and a closed Regulation Crowdfunding equity offering on StartEngine with a deadline of April 30, 2020.
Latest developments
The StartEngine equity crowdfunding offering, priced at $0.56 per share against a stated $5.96M valuation with a funding target range of $10K to $1.07M, reached its April 30, 2020 deadline and is shown as closed. Company profiles continue to list the business at five employees with a completed product.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
A small, early-stage consumer digital health hardware company in the connected diabetes management segment, listed alongside peers such as DarioHealth, Databetes, ithnain and Refvik Technologies.
The company positions GluCase as the first smartphone case-based diabetes management system and the first OtterBox-enabled smartphone case glucometer, consolidating meter, strips and connectivity into a phone case so users avoid carrying separate supplies, and layering contextual coaching driven by predictive analytics on top of raw glucose readings.
Technology
GluCase integrates a glucose monitoring kit and a Bluetooth module into a smartphone case compatible with OtterBox, transmitting readings to a mobile app. The app applies data science and predictive analytics to glucose, activity and diet data to generate real-time coaching and behavior-change recommendations.
Go-to-market
The product is sold direct to consumers as a monthly subscription bundling device, test strips and app access. The company raised capital directly from retail investors via a Regulation Crowdfunding equity campaign on StartEngine, and used a consumer blog covering diabetes self-management topics as an audience-building channel.
Consumers living with type 1 and type 2 diabetes who self-monitor blood glucose.
Geography
Headquarters in San Jose, California, with listings citing locations in San Jose and the United States generally; geographic exposure is described as United States.
History
The company was founded in July 2013 and is incorporated as a C-corp headquartered in San Jose, California. It participated in the Techstars: Sprint accelerator in 2014 and maintained a consumer-facing diabetes education blog through at least mid-2015, moving that blog to a new platform in June 2015. In 2019-2020 it offered common stock to retail investors through a Regulation Crowdfunding campaign on StartEngine, which closed on April 30, 2020. Company listings describe a headcount of five and a product stage of "full product ready."
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsAkibah Health ran an equity crowdfunding offering of common stock on StartEngine at $0.56 per share with a stated $5.96M valuation, a funding goal range of $10K to $1.07M, and a deadline of April 30, 2020. The offering is listed as closed.
The company announced a redesigned blog, directing readers to akibah.wordpress.com.
Akibah Health took part in the Techstars: Sprint accelerator program in 2014.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structure▸Research sources · 8
primary sources listed
- AkibaH Healthblog.akibah.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Akibah Health do?
- Akibah Health makes GluCase, a subscription smartphone-case glucometer and app for data-driven diabetes management.
- Who are Akibah Health's investors?
- Akibah Health's investors include Techstars.
- How much funding has Akibah Health raised?
- Akibah Health has disclosed $17.5K raised across 1 round.
- Where is Akibah Health headquartered?
- Akibah Health is headquartered in San Jose, US.